Literature DB >> 31696459

Steroids and growth factors in oral squamous cell carcinoma: useful source of dental-derived stem cells to develop a steroidogenic model in new clinical strategies.

M Boccellino1, D Di Stasio, G Dipalma, S Cantore, P Ambrosio, M Coppola, L Quagliuolo, A Scarano, G Malcangi, E Borsani, B Rinaldi, M Nuzzolese, E Xhajanka, A Ballini, F Inchingolo, M Di Domenico.   

Abstract

OBJECTIVE: Head and neck region is involved in a high percentage of malignant lesions, and oral squamous cell carcinoma (OSCC) is undoubtedly the most frequently found, accounting for over 90% of malignant tumors. Hormone receptor overexpression, like Estrogen Receptor (ER), Progesterone Receptor (PR) and Endothelial Growth Factor Receptor (EGFR), and signaling have been related to the pathogenesis of OSCC. For metastasis of OSCC, Cancer Stem Cells (CSCs) undergo epithelial to mesenchymal transition (EMT) under the influence of growth factors, cytokines, and regulation of cadherins from the tumor's microenvironment. In this context, the stem cells may become a potential therapeutic target for OSCC through modulation of cytokines and RAS pathway, which is involved in intracell signal transduction. The objective of this study was to suggest an experimental steroidogenic model for OSCC in translational research. PATIENTS AND METHODS: Dental-derived Stem Cells (D-dSCs) have been obtained from apical papilla tissue that surrounds the developing tooth of healthy donors and cultured in vitro. The cells have been exposed to different concentrations of Estradiol (E2 - 10 nM and 40 nM) in order to verify their response. The number of cells and cell viability has been evaluated up to 96 hours of treatment.
RESULTS: The results showed that cell growth was increased under estradiol treatments compared with cells maintained without estradiol. Moreover, no significant difference in cell death levels was detected among treatments.
CONCLUSIONS: This work underlines as D-dSCs could represent a useful steroidogenic model for the development of the target and gene therapies in OSCC.

Entities:  

Year:  2019        PMID: 31696459     DOI: 10.26355/eurrev_201910_19267

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  6 in total

1.  Hormone receptors AR, ER, PR and growth factor receptor Her-2 expression in oral squamous cell carcinoma: Correlation with overall survival, disease-free survival and 10-year survival in a high-risk population.

Authors:  Yumna Adnan; Syed Muhammad Adnan Ali; Muhammad Sohail Awan; Romana Idress; Muhammad Ozair Awan; Hasnain Ahmed Farooqui; Hammad Afzal Kayani
Journal:  PLoS One       Date:  2022-05-11       Impact factor: 3.752

Review 2.  Synthetic Scaffold/Dental Pulp Stem Cell (DPSC) Tissue Engineering Constructs for Bone Defect Treatment: An Animal Studies Literature Review.

Authors:  Felice Lorusso; Francesco Inchingolo; Gianna Dipalma; Francesca Postiglione; Stefania Fulle; Antonio Scarano
Journal:  Int J Mol Sci       Date:  2020-12-21       Impact factor: 5.923

3.  Comparison of Androgen Receptor, VEGF, HIF-1, Ki67 and MMP9 Expression between Non-Metastatic and Metastatic Stages in Stromal and Tumor Cells of Oral Squamous Cell Carcinoma.

Authors:  Lovorka Batelja-Vuletic; Cedna Tomasovic-Loncaric; Marcello Ceppi; Marco Bruzzone; Aleksandra Fucic; Karolina Krstanac; Vanja Boras Vucicevic
Journal:  Life (Basel)       Date:  2021-04-10

4.  High-Definition Ultrasound Characterization of Squamous Carcinoma of the Tongue: A Descriptive Observational Study.

Authors:  Dario Di Stasio; Marco Montella; Antonio Romano; Giuseppe Colella; Rosario Serpico; Alberta Lucchese
Journal:  Cancers (Basel)       Date:  2022-01-23       Impact factor: 6.639

Review 5.  Oral Cancer: A Historical Review.

Authors:  Francesco Inchingolo; Luigi Santacroce; Andrea Ballini; Skender Topi; Gianna Dipalma; Kastriot Haxhirexha; Lucrezia Bottalico; Ioannis Alexandros Charitos
Journal:  Int J Environ Res Public Health       Date:  2020-05-02       Impact factor: 3.390

Review 6.  SARS-CoV-2 Disease Adjuvant Therapies and Supplements Breakthrough for the Infection Prevention.

Authors:  Alessio Danilo Inchingolo; Angelo Michele Inchingolo; Ioana Roxana Bordea; Giuseppina Malcangi; Edit Xhajanka; Antonio Scarano; Felice Lorusso; Marco Farronato; Gianluca Martino Tartaglia; Ciro Gargiulo Isacco; Grazia Marinelli; Maria Teresa D'Oria; Denisa Hazballa; Luigi Santacroce; Andrea Ballini; Maria Contaldo; Francesco Inchingolo; Gianna Dipalma
Journal:  Microorganisms       Date:  2021-03-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.